☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Abivax
Abivax Publishes Results of Obefazimod (ABX464) in P-IIb Trial for the Treatment of Ulcerative Colitis in the Lancet Gastroenterol...
September 6, 2022
Abivax Reports One-Year Maintenance Results of ABX464 in P-IIa Trial for the Treatment with Rheumatoid Arthritis
March 10, 2022
Insights+: COVID-19 Healthcare News Monthly Updates - June 2020
June 30, 2020
Insights+: COVID-19 Healthcare News Monthly Updates - May 2020
May 29, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.